Climate Change Crisis Real Impact I Acquisition Corporation
Climate Change Crisis Real Impact I Acquisition Corporation (CLII) Stock Competitors & Peer Comparison
See (CLII) competitors and their performances in Stock Market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLII | $14.36 | -4.39% | 3.8B | N/A | N/A | N/A |
| CCIV | $24.25 | +5.90% | 44.4B | N/A | N/A | N/A |
| SYM | $52.99 | -0.80% | 32.1B | -662.37 | -$0.08 | N/A |
| PSACU | $17.08 | +0.35% | 12B | -108.79 | -$0.16 | N/A |
| RTPY | $9.91 | -0.30% | 11.6B | N/A | N/A | N/A |
| LVRAW | $0.04 | +0.00% | 11.5B | N/A | N/A | N/A |
| CMLFU | $13.00 | -4.55% | 10.3B | -1444.44 | -$0.01 | N/A |
| PSAC | $13.78 | -0.36% | 9.7B | N/A | N/A | N/A |
| GRSVU | $11.39 | +3.36% | 6.8B | N/A | N/A | N/A |
| APSG | $7.39 | -25.88% | 6.3B | 36.95 | $0.20 | N/A |
Stock Comparison
CLII vs CCIV Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, CLII is priced at $14.36, while CCIV trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CCIV's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to CCIV's ROE of -0.69%. Regarding short-term risk, CLII is less volatile compared to CCIV. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check CCIV's competition here
CLII vs SYM Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SYM has a market cap of 32.1B. Regarding current trading prices, CLII is priced at $14.36, while SYM trades at $52.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SYM's P/E ratio is -662.37. In terms of profitability, CLII's ROE is +0.71%, compared to SYM's ROE of -0.06%. Regarding short-term risk, CLII is more volatile compared to SYM. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check SYM's competition here
CLII vs PSACU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, CLII is priced at $14.36, while PSACU trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas PSACU's P/E ratio is -108.79. In terms of profitability, CLII's ROE is +0.71%, compared to PSACU's ROE of -0.42%. Regarding short-term risk, CLII is less volatile compared to PSACU. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check PSACU's competition here
CLII vs RTPY Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, CLII is priced at $14.36, while RTPY trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas RTPY's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to RTPY's ROE of -0.73%. Regarding short-term risk, CLII is more volatile compared to RTPY. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check RTPY's competition here
CLII vs LVRAW Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, CLII is priced at $14.36, while LVRAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas LVRAW's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to LVRAW's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to LVRAW. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check LVRAW's competition here
CLII vs CMLFU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CMLFU has a market cap of 10.3B. Regarding current trading prices, CLII is priced at $14.36, while CMLFU trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, CLII's ROE is +0.71%, compared to CMLFU's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to CMLFU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check CMLFU's competition here
CLII vs PSAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, CLII is priced at $14.36, while PSAC trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas PSAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to PSAC's ROE of -0.42%. Regarding short-term risk, CLII is less volatile compared to PSAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check PSAC's competition here
CLII vs GRSVU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, CLII is priced at $14.36, while GRSVU trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GRSVU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to GRSVU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check GRSVU's competition here
CLII vs APSG Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, CLII is priced at $14.36, while APSG trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas APSG's P/E ratio is 36.95. In terms of profitability, CLII's ROE is +0.71%, compared to APSG's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to APSG. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check APSG's competition here
CLII vs RTP Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, CLII is priced at $14.36, while RTP trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas RTP's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to RTP's ROE of -0.80%. Regarding short-term risk, CLII is more volatile compared to RTP. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check RTP's competition here
CLII vs DGNR Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, CLII is priced at $14.36, while DGNR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DGNR's P/E ratio is -308.67. In terms of profitability, CLII's ROE is +0.71%, compared to DGNR's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to DGNR. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check DGNR's competition here
CLII vs VTIQ Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, CLII is priced at $14.36, while VTIQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, CLII's ROE is +0.71%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, CLII is more volatile compared to VTIQ. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check VTIQ's competition here
CLII vs VTIQU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, CLII is priced at $14.36, while VTIQU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, CLII's ROE is +0.71%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, CLII is more volatile compared to VTIQU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check VTIQU's competition here
CLII vs VACQ Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, CLII is priced at $14.36, while VACQ trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas VACQ's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to VACQ's ROE of -0.59%. Regarding short-term risk, CLII is less volatile compared to VACQ. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check VACQ's competition here
CLII vs SVFC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, CLII is priced at $14.36, while SVFC trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SVFC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SVFC's ROE of -0.02%. Regarding short-term risk, CLII is more volatile compared to SVFC. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check SVFC's competition here
CLII vs VGAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, CLII is priced at $14.36, while VGAC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas VGAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to VGAC's ROE of -1.65%. Regarding short-term risk, CLII is more volatile compared to VGAC. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check VGAC's competition here
CLII vs CMLT Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CMLT has a market cap of 4.2B. Regarding current trading prices, CLII is priced at $14.36, while CMLT trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CMLT's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to CMLT's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to CMLT. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check CMLT's competition here
CLII vs GHVI Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, CLII is priced at $14.36, while GHVI trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GHVI's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to GHVI's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to GHVI. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check GHVI's competition here
CLII vs KVSB Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, CLII is priced at $14.36, while KVSB trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas KVSB's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to KVSB's ROE of -0.20%. Regarding short-term risk, CLII is less volatile compared to KVSB. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check KVSB's competition here
CLII vs FTOCU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, CLII is priced at $14.36, while FTOCU trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FTOCU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FTOCU's ROE of +0.16%. Regarding short-term risk, CLII is more volatile compared to FTOCU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FTOCU's competition here
CLII vs THCBU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, CLII is priced at $14.36, while THCBU trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas THCBU's P/E ratio is -101.87. In terms of profitability, CLII's ROE is +0.71%, compared to THCBU's ROE of +0.28%. Regarding short-term risk, CLII is more volatile compared to THCBU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check THCBU's competition here
CLII vs GRNV Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, CLII is priced at $14.36, while GRNV trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GRNV's P/E ratio is -59.68. In terms of profitability, CLII's ROE is +0.71%, compared to GRNV's ROE of -101981.32%. Regarding short-term risk, CLII is less volatile compared to GRNV. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check GRNV's competition here
CLII vs FRX Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, CLII is priced at $14.36, while FRX trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FRX's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FRX's ROE of -0.34%. Regarding short-term risk, CLII is less volatile compared to FRX. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check FRX's competition here
CLII vs HOLUU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, CLII is priced at $14.36, while HOLUU trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HOLUU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, CLII is less volatile compared to HOLUU. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check HOLUU's competition here
CLII vs SSPK Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, CLII is priced at $14.36, while SSPK trades at $18.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SSPK's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SSPK's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to SSPK. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check SSPK's competition here
CLII vs FCACU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, CLII is priced at $14.36, while FCACU trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FCACU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to FCACU. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check FCACU's competition here
CLII vs CFVI Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, CLII is priced at $14.36, while CFVI trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CFVI's P/E ratio is -18.55. In terms of profitability, CLII's ROE is +0.71%, compared to CFVI's ROE of -1.87%. Regarding short-term risk, CLII is less volatile compared to CFVI. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check CFVI's competition here
CLII vs HOL Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, CLII is priced at $14.36, while HOL trades at $12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HOL's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to HOL's ROE of -0.13%. Regarding short-term risk, CLII is less volatile compared to HOL. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check HOL's competition here
CLII vs THCB Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, CLII is priced at $14.36, while THCB trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas THCB's P/E ratio is -81.30. In terms of profitability, CLII's ROE is +0.71%, compared to THCB's ROE of +0.28%. Regarding short-term risk, CLII is less volatile compared to THCB. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check THCB's competition here
CLII vs SOAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, CLII is priced at $14.36, while SOAC trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SOAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SOAC's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to SOAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check SOAC's competition here
CLII vs FUSE Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FUSE has a market cap of 2.8B. Regarding current trading prices, CLII is priced at $14.36, while FUSE trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FUSE's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FUSE's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to FUSE. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check FUSE's competition here
CLII vs DCRBU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, CLII is priced at $14.36, while DCRBU trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, CLII's ROE is +0.71%, compared to DCRBU's ROE of -2.38%. Regarding short-term risk, CLII is more volatile compared to DCRBU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check DCRBU's competition here
CLII vs IVAN Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, CLII is priced at $14.36, while IVAN trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas IVAN's P/E ratio is -698.18. In terms of profitability, CLII's ROE is +0.71%, compared to IVAN's ROE of -0.33%. Regarding short-term risk, CLII is less volatile compared to IVAN. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check IVAN's competition here
CLII vs GWAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, CLII is priced at $14.36, while GWAC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GWAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to GWAC's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to GWAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check GWAC's competition here
CLII vs LCYAU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, CLII is priced at $14.36, while LCYAU trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas LCYAU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to LCYAU's ROE of +0.05%. Regarding short-term risk, CLII is more volatile compared to LCYAU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check LCYAU's competition here
CLII vs APXTU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, APXTU has a market cap of 2.5B. Regarding current trading prices, CLII is priced at $14.36, while APXTU trades at $13.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas APXTU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to APXTU's ROE of -0.01%. Regarding short-term risk, CLII is more volatile compared to APXTU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check APXTU's competition here
CLII vs FWAA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, CLII is priced at $14.36, while FWAA trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FWAA's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FWAA's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to FWAA. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FWAA's competition here
CLII vs GSAH Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, CLII is priced at $14.36, while GSAH trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GSAH's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to GSAH's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to GSAH. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check GSAH's competition here
CLII vs LCY Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, CLII is priced at $14.36, while LCY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas LCY's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to LCY's ROE of +0.05%. Regarding short-term risk, CLII is more volatile compared to LCY. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check LCY's competition here
CLII vs FORE Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, CLII is priced at $14.36, while FORE trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FORE's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FORE's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to FORE. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FORE's competition here
CLII vs APXT Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, APXT has a market cap of 2.3B. Regarding current trading prices, CLII is priced at $14.36, while APXT trades at $12.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas APXT's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to APXT's ROE of -0.01%. Regarding short-term risk, CLII is more volatile compared to APXT. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check APXT's competition here
CLII vs MNTN Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, MNTN has a market cap of 2.2B. Regarding current trading prices, CLII is priced at $14.36, while MNTN trades at $28.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas MNTN's P/E ratio is -57.20. In terms of profitability, CLII's ROE is +0.71%, compared to MNTN's ROE of -0.36%. Regarding short-term risk, CLII is more volatile compared to MNTN. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check MNTN's competition here
CLII vs RAAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, CLII is priced at $14.36, while RAAC trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas RAAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to RAAC. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check RAAC's competition here
CLII vs SPNV Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, CLII is priced at $14.36, while SPNV trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SPNV's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SPNV's ROE of -1.07%. Regarding short-term risk, CLII is more volatile compared to SPNV. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check SPNV's competition here
CLII vs DNAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, CLII is priced at $14.36, while DNAC trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DNAC's P/E ratio is -37.72. In terms of profitability, CLII's ROE is +0.71%, compared to DNAC's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to DNAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DNAC's competition here
CLII vs FAII Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, CLII is priced at $14.36, while FAII trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FAII's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FAII's ROE of -0.32%. Regarding short-term risk, CLII is more volatile compared to FAII. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FAII's competition here
CLII vs DMYI Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, CLII is priced at $14.36, while DMYI trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DMYI's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to DMYI's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to DMYI. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DMYI's competition here
CLII vs LOKB Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, CLII is priced at $14.36, while LOKB trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas LOKB's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to LOKB's ROE of -0.27%. Regarding short-term risk, CLII is less volatile compared to LOKB. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check LOKB's competition here
CLII vs STPC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, STPC has a market cap of 2B. Regarding current trading prices, CLII is priced at $14.36, while STPC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas STPC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to STPC's ROE of -0.29%. Regarding short-term risk, CLII is more volatile compared to STPC. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check STPC's competition here
CLII vs MUDS Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, CLII is priced at $14.36, while MUDS trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas MUDS's P/E ratio is 3.39. In terms of profitability, CLII's ROE is +0.71%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, CLII is more volatile compared to MUDS. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check MUDS's competition here
CLII vs MUDSU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, CLII is priced at $14.36, while MUDSU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, CLII's ROE is +0.71%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, CLII is more volatile compared to MUDSU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check MUDSU's competition here
CLII vs TINV Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, TINV has a market cap of 2B. Regarding current trading prices, CLII is priced at $14.36, while TINV trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas TINV's P/E ratio is 30.61. In terms of profitability, CLII's ROE is +0.71%, compared to TINV's ROE of -2.84%. Regarding short-term risk, CLII is less volatile compared to TINV. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check TINV's competition here
CLII vs CMII Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CMII has a market cap of 2B. Regarding current trading prices, CLII is priced at $14.36, while CMII trades at $10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CMII's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to CMII's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to CMII. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check CMII's competition here
CLII vs DWAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, CLII is priced at $14.36, while DWAC trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DWAC's P/E ratio is -73.46. In terms of profitability, CLII's ROE is +0.71%, compared to DWAC's ROE of -0.58%. Regarding short-term risk, CLII is less volatile compared to DWAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DWAC's competition here
CLII vs DWACU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, CLII is priced at $14.36, while DWACU trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DWACU's P/E ratio is -451.10. In terms of profitability, CLII's ROE is +0.71%, compared to DWACU's ROE of -0.14%. Regarding short-term risk, CLII is less volatile compared to DWACU. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DWACU's competition here
CLII vs ATHN Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, CLII is priced at $14.36, while ATHN trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas ATHN's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to ATHN's ROE of -4.14%. Regarding short-term risk, CLII is less volatile compared to ATHN. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check ATHN's competition here
CLII vs GMII Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, CLII is priced at $14.36, while GMII trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GMII's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to GMII's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to GMII. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check GMII's competition here
CLII vs SVACU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SVACU has a market cap of 1.8B. Regarding current trading prices, CLII is priced at $14.36, while SVACU trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SVACU's P/E ratio is -22.89. In terms of profitability, CLII's ROE is +0.71%, compared to SVACU's ROE of -0.04%. Regarding short-term risk, CLII is more volatile compared to SVACU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check SVACU's competition here
CLII vs MOTV Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, CLII is priced at $14.36, while MOTV trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas MOTV's P/E ratio is 55.86. In terms of profitability, CLII's ROE is +0.71%, compared to MOTV's ROE of -0.17%. Regarding short-term risk, CLII is less volatile compared to MOTV. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check MOTV's competition here
CLII vs SVAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SVAC has a market cap of 1.7B. Regarding current trading prices, CLII is priced at $14.36, while SVAC trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SVAC's P/E ratio is -32.05. In terms of profitability, CLII's ROE is +0.71%, compared to SVAC's ROE of -0.04%. Regarding short-term risk, CLII is more volatile compared to SVAC. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check SVAC's competition here
CLII vs CBAH Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, CLII is priced at $14.36, while CBAH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CBAH's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to CBAH's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to CBAH. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check CBAH's competition here
CLII vs GXGXU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, CLII is priced at $14.36, while GXGXU trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, CLII's ROE is +0.71%, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, CLII is less volatile compared to GXGXU. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check GXGXU's competition here
CLII vs AONE Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, CLII is priced at $14.36, while AONE trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas AONE's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to AONE's ROE of -0.06%. Regarding short-term risk, CLII is less volatile compared to AONE. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check AONE's competition here
CLII vs SNPR Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, CLII is priced at $14.36, while SNPR trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SNPR's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to SNPR. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check SNPR's competition here
CLII vs SPFR Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, CLII is priced at $14.36, while SPFR trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SPFR's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SPFR's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to SPFR. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check SPFR's competition here
CLII vs DEH Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, CLII is priced at $14.36, while DEH trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DEH's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to DEH's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to DEH. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DEH's competition here
CLII vs ROT Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, CLII is priced at $14.36, while ROT trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas ROT's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to ROT's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to ROT. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check ROT's competition here
CLII vs NGAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, CLII is priced at $14.36, while NGAC trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas NGAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to NGAC's ROE of N/A. Regarding short-term risk, CLII is more volatile compared to NGAC. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check NGAC's competition here
CLII vs GXGX Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, GXGX has a market cap of 1.5B. Regarding current trading prices, CLII is priced at $14.36, while GXGX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas GXGX's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to GXGX's ROE of -3.35%. Regarding short-term risk, CLII is less volatile compared to GXGX. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check GXGX's competition here
CLII vs HECCU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, CLII is priced at $14.36, while HECCU trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HECCU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to HECCU's ROE of -0.06%. Regarding short-term risk, CLII is more volatile compared to HECCU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check HECCU's competition here
CLII vs ATMR Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, CLII is priced at $14.36, while ATMR trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas ATMR's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to ATMR's ROE of +0.20%. Regarding short-term risk, CLII is less volatile compared to ATMR. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check ATMR's competition here
CLII vs SFTW Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, CLII is priced at $14.36, while SFTW trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SFTW's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SFTW's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to SFTW. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check SFTW's competition here
CLII vs ENFA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while ENFA trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas ENFA's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to ENFA's ROE of -825.62%. Regarding short-term risk, CLII is less volatile compared to ENFA. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check ENFA's competition here
CLII vs ENVI Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while ENVI trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas ENVI's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to ENVI. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check ENVI's competition here
CLII vs DFNS Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DFNS has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while DFNS trades at $12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DFNS's P/E ratio is -17.39. In terms of profitability, CLII's ROE is +0.71%, compared to DFNS's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to DFNS. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DFNS's competition here
CLII vs ACTD Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while ACTD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas ACTD's P/E ratio is -25.50. In terms of profitability, CLII's ROE is +0.71%, compared to ACTD's ROE of +0.69%. Regarding short-term risk, CLII is less volatile compared to ACTD. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check ACTD's competition here
CLII vs VCKA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while VCKA trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas VCKA's P/E ratio is 100.11. In terms of profitability, CLII's ROE is +0.71%, compared to VCKA's ROE of +0.36%. Regarding short-term risk, CLII is less volatile compared to VCKA. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check VCKA's competition here
CLII vs THMA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while THMA trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas THMA's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to THMA's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to THMA. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check THMA's competition here
CLII vs LNFA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while LNFA trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas LNFA's P/E ratio is 21.06. In terms of profitability, CLII's ROE is +0.71%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, CLII is less volatile compared to LNFA. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check LNFA's competition here
CLII vs FTIVU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while FTIVU trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FTIVU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FTIVU's ROE of -0.41%. Regarding short-term risk, CLII is less volatile compared to FTIVU. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check FTIVU's competition here
CLII vs STWO Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, CLII is priced at $14.36, while STWO trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas STWO's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to STWO's ROE of -1.71%. Regarding short-term risk, CLII is less volatile compared to STWO. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check STWO's competition here
CLII vs HYACU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, CLII is priced at $14.36, while HYACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HYACU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to HYACU's ROE of +0.06%. Regarding short-term risk, CLII is more volatile compared to HYACU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check HYACU's competition here
CLII vs FTIV Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, CLII is priced at $14.36, while FTIV trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FTIV's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FTIV's ROE of -0.41%. Regarding short-term risk, CLII is more volatile compared to FTIV. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FTIV's competition here
CLII vs AHAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while AHAC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas AHAC's P/E ratio is -72.11. In terms of profitability, CLII's ROE is +0.71%, compared to AHAC's ROE of +2.86%. Regarding short-term risk, CLII is less volatile compared to AHAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check AHAC's competition here
CLII vs AMHC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while AMHC trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas AMHC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to AMHC's ROE of -0.01%. Regarding short-term risk, CLII is less volatile compared to AMHC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check AMHC's competition here
CLII vs HERAW Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while HERAW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HERAW's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, CLII is less volatile compared to HERAW. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check HERAW's competition here
CLII vs HERA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while HERA trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HERA's P/E ratio is 46.32. In terms of profitability, CLII's ROE is +0.71%, compared to HERA's ROE of +0.01%. Regarding short-term risk, CLII is more volatile compared to HERA. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check HERA's competition here
CLII vs FGNA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while FGNA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FGNA's P/E ratio is -4.35. In terms of profitability, CLII's ROE is +0.71%, compared to FGNA's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to FGNA. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FGNA's competition here
CLII vs DNAA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while DNAA trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas DNAA's P/E ratio is -54.53. In terms of profitability, CLII's ROE is +0.71%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, CLII is less volatile compared to DNAA. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check DNAA's competition here
CLII vs RACA Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while RACA trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas RACA's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to RACA's ROE of +0.00%. Regarding short-term risk, CLII is more volatile compared to RACA. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check RACA's competition here
CLII vs TREB Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while TREB trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas TREB's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to TREB's ROE of -0.00%. Regarding short-term risk, CLII is less volatile compared to TREB. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check TREB's competition here
CLII vs PACE Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while PACE trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas PACE's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to PACE's ROE of -1.08%. Regarding short-term risk, CLII is more volatile compared to PACE. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check PACE's competition here
CLII vs HERAU Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while HERAU trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas HERAU's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, CLII is more volatile compared to HERAU. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check HERAU's competition here
CLII vs LSAQ Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, CLII is priced at $14.36, while LSAQ trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas LSAQ's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to LSAQ's ROE of N/A. Regarding short-term risk, CLII is less volatile compared to LSAQ. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check LSAQ's competition here
CLII vs SRAC Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, CLII is priced at $14.36, while SRAC trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SRAC's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SRAC's ROE of -0.02%. Regarding short-term risk, CLII is less volatile compared to SRAC. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check SRAC's competition here
CLII vs FTPAW Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, CLII is priced at $14.36, while FTPAW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas FTPAW's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, CLII is more volatile compared to FTPAW. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check FTPAW's competition here
CLII vs SBG Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, SBG has a market cap of 1B. Regarding current trading prices, CLII is priced at $14.36, while SBG trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas SBG's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to SBG's ROE of -3.85%. Regarding short-term risk, CLII is less volatile compared to SBG. This indicates potentially lower risk in terms of short-term price fluctuations for CLII.Check SBG's competition here
CLII vs MTAL Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, MTAL has a market cap of 996.1M. Regarding current trading prices, CLII is priced at $14.36, while MTAL trades at $12.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas MTAL's P/E ratio is -10.60. In terms of profitability, CLII's ROE is +0.71%, compared to MTAL's ROE of -0.15%. Regarding short-term risk, CLII is more volatile compared to MTAL. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check MTAL's competition here
CLII vs CVII-WT Comparison July 2025
CLII plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLII stands at 3.8B. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, CLII is priced at $14.36, while CVII-WT trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLII currently has a P/E ratio of N/A, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, CLII's ROE is +0.71%, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, CLII is more volatile compared to CVII-WT. This indicates potentially higher risk in terms of short-term price fluctuations for CLII.Check CVII-WT's competition here